CA19-9 serum levels predict micrometastases in patients with gastric cancer

Jagric Tomaz; Potrc Stojan; Mis Katarina; Plankl Mojca; Mars Tomaz

doi:10.1515/raon-2015-0025

Radiology and Oncology (Jun 2016)

CA19-9 serum levels predict micrometastases in patients with gastric cancer

Jagric Tomaz,
Potrc Stojan,
Mis Katarina,
Plankl Mojca,
Mars Tomaz

Affiliations

Jagric Tomaz: Department of Abdominal and General Surgery, University Medical Centre Maribor, Maribor, Sloveni
Potrc Stojan: Institute of Pathophysiology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Mis Katarina: Institute of Pathophysiology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Plankl Mojca: Institute of Pathophysiology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Mars Tomaz: Institute of Pathophysiology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

DOI: https://doi.org/10.1515/raon-2015-0025
Journal volume & issue: Vol. 50, no. 2
pp. 204 – 211

Abstract

Read online

We explored the prognostic value of the up-regulated carbohydrate antigen (CA19-9) in node-negative patients with gastric cancer as a surrogate marker for micrometastases.

Published in Radiology and Oncology

ISSN: 1581-3207 (Online)
Publisher: Sciendo
Country of publisher: Slovenia
LCC subjects: Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine
Website: https://sciendo.com/journal/RAON

About the journal

Abstract

Keywords